The XIAP inhibitor AZD5582 improves the treatment effect of microwave ablation on hepatocellular carcinoma

Background and purposeMicrowave ablation (MWA) is one of the first-line therapy recommended for early-stage hepatocellular carcinoma (HCC). However, the residual tumor, resulting from insufficient ablation, led to recurrence and metastasis of liver cancer. Novel combination strategies are urgently n...

Descripció completa

Dades bibliogràfiques

Autors principals:	Wenhui Wang, Fuyuan Wu, Zhe Wu, Mengfan Zhang, Qiang Lu
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2025-01-01
Col·lecció:	Frontiers in Immunology
Matèries:	XIAP anti-tumor immunity hepatocellular carcinoma microwave ablation residual tumor
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1482954/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!